People on the Move
Bone Therapeutics
Belgian biopharma Bone Therapeutics – which makes bone disease and orthopaedic therapies – has appointed a former Pfizer team leader as its Chief Clinical and Regulatory Officer.
Guy Heynen is a specialist in rheumatology and immunology. He spent most of his career so far in roles at Pfizer, including Medical Director for Pfizer Switzerland, European Team Leader for the Alzheimer’s disease drug Aricept, and Medical Team Leader for Pfizer’s anti-inflammatory drug franchise based in New York.
Heynen also serves on the Boards of Euroscreen SA, Progenosis SA and as an advisor for Promethera Biosciences. He remains a Regional Medical Monitor for Pfizer GmbH.
